2 A crystal structure of an extracellular fragment of human CD40 ligand.
Karpusas, M., Hsu, Y.M., Wang, J.H., Thompson, J., Lederman, S., Chess, L., Thomas, D.(1995) Structure 3: 1031-1039
- PubMed: 8589998 
- DOI: https://doi.org/10.1016/s0969-2126(01)00239-8
- Primary Citation of Related Structures:  
1ALY - PubMed Abstract: 
The CD40 ligand (CD40L) is a member of the tumor necrosis factor (TNF) family of proteins and is transiently expressed on the surface of activated T cells. The binding of CD40L to CD40, which is expressed on the surface of B cells, provides a critical and unique pathway of cellular activation resulting in antibody isotype switching, regulation of apoptosis, and B cell proliferation and differentiation. Naturally occurring mutations of CD40L result in the clinical hyper-IgM syndrome, characterized by an inability to produce immunoglobulins of the IgG, IgA and IgE isotypes.
Organizational Affiliation: 
Biogen, Inc., Cambridge, MA 02142, USA.